Published in J Virol on December 26, 2007
Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2. Curr Opin Cell Biol (2009) 3.15
Cell cycle G2/M arrest through an S phase-dependent mechanism by HIV-1 viral protein R. Retrovirology (2010) 0.97
Molecular Mechanisms of Neurodegenerative Diseases Induced by Human Retroviruses: A Review. Am J Infect Dis (2009) 0.86
HIV-1 viral protein R (Vpr) and its interactions with host cell. Curr HIV Res (2009) 0.81
HIV-1 replication through hHR23A-mediated interaction of Vpr with 26S proteasome. PLoS One (2010) 0.81
Cytotoxic activity of the MK2 inhibitor CMPD1 in glioblastoma cells is independent of MK2. Cell Death Discov (2015) 0.81
HIV-1 Protease in the Fission Yeast Schizosaccharomyces pombe. PLoS One (2016) 0.78
Molecular genetic analysis of fission yeast Schizosaccharomyces pombe. Methods Enzymol (1991) 33.90
Genetic control of the cell division cycle in the fission yeast Schizosaccharomyces pombe. Mol Gen Genet (1976) 9.64
Thiamine-repressible expression vectors pREP and pRIP for fission yeast. Gene (1993) 9.36
Cdc25 mitotic inducer targeted by chk1 DNA damage checkpoint kinase. Science (1997) 9.30
Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science (1997) 8.43
Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science (1997) 8.24
The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc Natl Acad Sci U S A (1994) 7.85
Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J Virol (1995) 7.57
Nuclear localization of Cdc25 is regulated by DNA damage and a 14-3-3 protein. Nature (1999) 5.38
The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle. J Virol (1995) 4.42
HIV-1: fifteen proteins and an RNA. Annu Rev Biochem (1998) 4.33
Leptomycin B targets a regulatory cascade of crm1, a fission yeast nuclear protein, involved in control of higher order chromosome structure and gene expression. J Biol Chem (1994) 4.28
Replication checkpoint enforced by kinases Cds1 and Chk1. Science (1998) 4.22
The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection. J Virol (1995) 4.19
Progression to AIDS in the absence of a gene for vpr or vpx. J Virol (1995) 3.96
Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B. J Virol (1995) 3.69
HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo. Nat Med (1998) 3.61
The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01. J Biol Chem (2000) 3.49
MAPKAP kinase-2 is a cell cycle checkpoint kinase that regulates the G2/M transition and S phase progression in response to UV irradiation. Mol Cell (2005) 3.48
Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus. J Virol (1993) 3.37
Replication checkpoint requires phosphorylation of the phosphatase Cdc25 by Cds1 or Chk1. Nature (1998) 3.36
Binding of 14-3-3 proteins and nuclear export control the intracellular localization of the mitotic inducer Cdc25. Genes Dev (1999) 2.89
Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control. J Virol (1996) 2.86
The human immunodeficiency virus type 2 vpr gene is essential for productive infection of human macrophages. Proc Natl Acad Sci U S A (1990) 2.84
Activation of the ATR-mediated DNA damage response by the HIV-1 viral protein R. J Biol Chem (2003) 2.26
Cytoplasmic localization of human cdc25C during interphase requires an intact 14-3-3 binding site. Mol Cell Biol (1999) 2.21
Role for the PP2A/B56delta phosphatase in regulating 14-3-3 release from Cdc25 to control mitosis. Cell (2006) 2.15
Cdc25 inhibited in vivo and in vitro by checkpoint kinases Cds1 and Chk1. Mol Biol Cell (1999) 2.14
Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1994) 2.00
Cell cycle arrest by Vpr in HIV-1 virions and insensitivity to antiretroviral agents. Science (1998) 1.83
DNA damage and replication checkpoints in fission yeast require nuclear exclusion of the Cdc25 phosphatase via 14-3-3 binding. Mol Cell Biol (1999) 1.81
Cell cycle control genes in fission yeast and mammalian cells. Trends Genet (1988) 1.77
Human immunodeficiency virus type 1 Vpr-mediated G2 arrest requires Rad17 and Hus1 and induces nuclear BRCA1 and gamma-H2AX focus formation. Mol Cell Biol (2004) 1.66
Inactivation of the Cdc25 phosphatase by the stress-activated Srk1 kinase in fission yeast. Mol Cell (2005) 1.56
14-3-3 proteins associate with cdc25 phosphatases. Proc Natl Acad Sci U S A (1995) 1.44
In vivo localisation of fission yeast cyclin-dependent kinase cdc2p and cyclin B cdc13p during mitosis and meiosis. J Cell Sci (2001) 1.38
Activation of the ATR pathway by human immunodeficiency virus type 1 Vpr involves its direct binding to chromatin in vivo. J Virol (2005) 1.34
A role for PP1 in the Cdc2/Cyclin B-mediated positive feedback activation of Cdc25. Mol Biol Cell (2006) 1.31
The Srk1 protein kinase is a target for the Sty1 stress-activated MAPK in fission yeast. J Biol Chem (2002) 1.30
Evidence for a cytopathogenicity determinant in HIV-1 Vpr. Proc Natl Acad Sci U S A (2002) 1.27
Regulation of mitotic inhibitor Mik1 helps to enforce the DNA damage checkpoint. Mol Biol Cell (2000) 1.25
Effect of human immunodeficiency virus type 1 protein R (vpr) gene expression on basic cellular function of fission yeast Schizosaccharomyces pombe. J Virol (1996) 1.24
HIV-1 Vpr induces cell cycle G2 arrest in fission yeast (Schizosaccharomyces pombe) through a pathway involving regulatory and catalytic subunits of PP2A and acting on both Wee1 and Cdc25. Virology (2001) 1.17
Viral infections and cell cycle G2/M regulation. Cell Res (2005) 1.13
Discovery and characterization of a substrate selective p38alpha inhibitor. Biochemistry (2004) 1.13
Vpr protein of human immunodeficiency virus type 1 binds to 14-3-3 proteins and facilitates complex formation with Cdc25C: implications for cell cycle arrest. J Virol (2005) 1.13
Changes in regulatory phosphorylation of Cdc25C Ser287 and Wee1 Ser549 during normal cell cycle progression and checkpoint arrests. Mol Biol Cell (2005) 1.13
Catalysis and function of the p38 alpha.MK2a signaling complex. Biochemistry (2004) 1.07
Increased levels of Wee-1 kinase in G(2) are necessary for Vpr- and gamma irradiation-induced G(2) arrest. J Virol (2004) 1.03
Partner molecules of accessory protein Vpr of the human immunodeficiency virus type 1. DNA Cell Biol (2004) 1.03
The human immunodeficiency virus Vpr protein binds Cdc25C: implications for G2 arrest. Virology (2004) 1.02
Upregulation of survivin by HIV-1 Vpr. Apoptosis (2003) 1.02
Cell cycle G2 arrest induced by HIV-1 Vpr in fission yeast (Schizosaccharomyces pombe) is independent of cell death and early genes in the DNA damage checkpoint. Virus Res (2000) 1.01
Phosphatase type 2A-dependent and -independent pathways for ATR phosphorylation of Chk1. J Biol Chem (2007) 0.99
The identification of Wos2, a p23 homologue that interacts with Wee1 and Cdc2 in the mitotic control of fission yeasts. Genetics (1999) 0.96
Mkp1 and Mkp2, two MAPKAP-kinase homologues in Schizosaccharomyces pombe, interact with the MAP kinase Sty1. Mol Genet Genomics (2003) 0.94
HIV-1 viral protein R (Vpr) & host cellular responses. Indian J Med Res (2005) 0.94
Optimization of the Tet-on system to regulate interleukin 12 expression in the liver for the treatment of hepatic tumors. Cancer Res (2004) 0.94
Functional conservation of HIV-1 Vpr and variability in a mother-child pair of long-term non-progressors. Virus Res (2002) 0.93
Schizosaccharomyces pombe checkpoint response to DNA interstrand cross-links. Mol Cell Biol (2003) 0.93
A novel inducible expression system to study transdominant mutants of HIV-1 Vpr. Virology (2001) 0.88
Anti-vpr activities of heat shock protein 27. Mol Med (2007) 0.87
Anti-Vpr activity of a yeast chaperone protein. J Virol (2004) 0.86
The sal3(+) gene encodes an importin-beta implicated in the nuclear import of Cdc25 in Schizosaccharomyces pombe. Genetics (2002) 0.82
Antagonistic interaction of HIV-1 Vpr with Hsf-mediated cellular heat shock response and Hsp16 in fission yeast (Schizosaccharomyces pombe). Retrovirology (2007) 0.82
HIV-1 Vpr induces G2 cell cycle arrest in fission yeast associated with Rad24/14-3-3-dependent, Chk1/Cds1-independent Wee1 upregulation. Microbes Infect (2006) 0.81
Low amounts of the DNA repair XPA protein are sufficient to recover UV-resistance. Carcinogenesis (2002) 0.81
Cumulative association of five genetic variants with prostate cancer. N Engl J Med (2008) 15.34
The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature (2011) 6.71
Glucose levels and risk of dementia. N Engl J Med (2013) 4.95
Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP. J Natl Cancer Inst (2007) 4.85
Pathological correlates of dementia in a longitudinal, population-based sample of aging. Ann Neurol (2007) 4.47
Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans. J Natl Cancer Inst (2007) 4.24
Age and apolipoprotein E*4 allele effects on cerebrospinal fluid beta-amyloid 42 in adults with normal cognition. Arch Neurol (2006) 2.79
The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-α. Nat Med (2012) 2.66
Blinded, multicenter comparison of methods to detect a drug-resistant mutant of human immunodeficiency virus type 1 at low frequency. J Clin Microbiol (2006) 2.45
The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementation. Clin Pharmacol Ther (2013) 2.39
Sequence variants at 22q13 are associated with prostate cancer risk. Cancer Res (2009) 2.27
Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice. Biomaterials (2009) 2.13
A chelator-free multifunctional [64Cu]CuS nanoparticle platform for simultaneous micro-PET/CT imaging and photothermal ablation therapy. J Am Chem Soc (2010) 2.02
Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study. Cancer Res (2004) 1.91
Effect of statins on Alzheimer's disease biomarkers in cerebrospinal fluid. J Alzheimers Dis (2006) 1.82
Blood pressure and brain injury in older adults: findings from a community-based autopsy study. J Am Geriatr Soc (2009) 1.76
Association of prostate cancer risk variants with clinicopathologic characteristics of the disease. Clin Cancer Res (2008) 1.74
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nat Commun (2013) 1.73
YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease. Biol Psychiatry (2010) 1.59
Inherited genetic variant predisposes to aggressive but not indolent prostate cancer. Proc Natl Acad Sci U S A (2010) 1.59
SNPs associated with cerebrospinal fluid phospho-tau levels influence rate of decline in Alzheimer's disease. PLoS Genet (2010) 1.58
Genetic deletions in sputum as diagnostic markers for early detection of stage I non-small cell lung cancer. Clin Cancer Res (2007) 1.57
Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk. J Natl Cancer Inst (2005) 1.55
Identification of microRNA-31 as a novel regulator contributing to impaired interleukin-2 production in T cells from patients with systemic lupus erythematosus. Arthritis Rheum (2012) 1.54
LL-37 enhances adaptive antitumor immune response in a murine model when genetically fused with M-CSFR (J6-1) DNA vaccine. Leuk Res (2005) 1.51
Up-regulation of 14-3-3zeta in lung cancer and its implication as prognostic and therapeutic target. Cancer Res (2007) 1.51
Multiple SNPs within and surrounding the apolipoprotein E gene influence cerebrospinal fluid apolipoprotein E protein levels. J Alzheimers Dis (2008) 1.40
Training future pharmacists at a minority educational institution: evaluation of the Rx for change tobacco cessation training program. Cancer Epidemiol Biomarkers Prev (2004) 1.39
Curcumin opens cystic fibrosis transmembrane conductance regulator channels by a novel mechanism that requires neither ATP binding nor dimerization of the nucleotide-binding domains. J Biol Chem (2006) 1.39
Clinical significance of IL-18 gene over-expression in AML. Leuk Res (2002) 1.39
Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. Nat Commun (2013) 1.36
Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease. PLoS One (2011) 1.32
Two-dimensional transport-induced linear magneto-resistance in topological insulator Bi2Se3 nanoribbons. ACS Nano (2011) 1.29
Association of a germ-line copy number variation at 2p24.3 and risk for aggressive prostate cancer. Cancer Res (2009) 1.29
Japanese encephalitis, Tibet, China. Emerg Infect Dis (2011) 1.26
Reversible silencing of CFTR chloride channels by glutathionylation. J Gen Physiol (2005) 1.22
Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians. Mutat Res (2004) 1.20
Multiplex asymmetric PCR-based oligonucleotide microarray for detection of drug resistance genes containing single mutations in Enterobacteriaceae. Antimicrob Agents Chemother (2007) 1.19
Systematic replication study of reported genetic associations in prostate cancer: Strong support for genetic variation in the androgen pathway. Prostate (2006) 1.19
Implementation of pharmacogenetics: the University of Maryland Personalized Anti-platelet Pharmacogenetics Program. Am J Med Genet C Semin Med Genet (2014) 1.19
ATP-independent CFTR channel gating and allosteric modulation by phosphorylation. Proc Natl Acad Sci U S A (2010) 1.19
Delayed senescence of apple leaves by exogenous melatonin treatment: toward regulating the ascorbate-glutathione cycle. J Pineal Res (2011) 1.18
Satellite-based PM concentrations and their application to COPD in Cleveland, OH. J Expo Sci Environ Epidemiol (2013) 1.16
Viral infections and cell cycle G2/M regulation. Cell Res (2005) 1.13
Highly selective and sensitive near-infrared-fluorescent probes for the detection of cellular hydrogen sulfide and the imaging of H2S in mice. Chem Asian J (2014) 1.12
Association of 17 prostate cancer susceptibility loci with prostate cancer risk in Chinese men. Prostate (2010) 1.12
DNA barcode goes two-dimensions: DNA QR code web server. PLoS One (2012) 1.12
A polymorphism in the CDKN1B gene is associated with increased risk of hereditary prostate cancer. Cancer Res (2004) 1.11
Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis. Clin Cancer Res (2005) 1.11
Activating cystic fibrosis transmembrane conductance regulator channels with pore blocker analogs. J Biol Chem (2005) 1.11
Heat shock protein 70 protects cells from cell cycle arrest and apoptosis induced by human immunodeficiency virus type 1 viral protein R. J Virol (2004) 1.11
Interactions of sequence variants in interleukin-1 receptor-associated kinase4 and the toll-like receptor 6-1-10 gene cluster increase prostate cancer risk. Cancer Epidemiol Biomarkers Prev (2006) 1.10
Socioeconomic status and hypertension: a meta-analysis. J Hypertens (2015) 1.09
Highly stable skyrmion state in helimagnetic MnSi nanowires. Nano Lett (2014) 1.08
Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer. BMC Cancer (2006) 1.07
Single-cell fluorescence imaging using metal plasmon-coupled probe 2: single-molecule counting on lifetime image. Nano Lett (2008) 1.07
MicroRNAs--novel regulators of systemic lupus erythematosus pathogenesis. Nat Rev Rheumatol (2012) 1.06
Utility of the trnH-psbA intergenic spacer region and its combinations as plant DNA barcodes: a meta-analysis. PLoS One (2012) 1.05
Inositol pyrophosphates mediate the effects of aging on bone marrow mesenchymal stem cells by inhibiting Akt signaling. Stem Cell Res Ther (2014) 1.04
Neuropathology in the adult changes in thought study: a review. J Alzheimers Dis (2009) 1.02
Healthy aging: an automatic analysis of global and regional morphological alterations of human brain. Acad Radiol (2012) 1.02
Highly undersampled magnetic resonance image reconstruction using two-level Bregman method with dictionary updating. IEEE Trans Med Imaging (2013) 1.02
IL-18 increases invasiveness of HL-60 myeloid leukemia cells: up-regulation of matrix metalloproteinases-9 (MMP-9) expression. Leuk Res (2004) 1.01
Genetic variants in TGF-β pathway are associated with ovarian cancer risk. PLoS One (2011) 1.01
Delay in leaf senescence of Malus hupehensis by long-term melatonin application is associated with its regulation of metabolic status and protein degradation. J Pineal Res (2013) 1.00
Progesterone increases systemic and local uterine proportions of CD4+CD25+ Treg cells during midterm pregnancy in mice. Endocrinology (2010) 1.00
Photothermal-chemotherapy with doxorubicin-loaded hollow gold nanospheres: A platform for near-infrared light-trigged drug release. J Control Release (2011) 1.00
InAs nanowire transistors as gas sensor and the response mechanism. Nano Lett (2009) 1.00
Apelin stimulates glucose uptake through the PI3K/Akt pathway and improves insulin resistance in 3T3-L1 adipocytes. Mol Cell Biochem (2011) 0.99
2-(Benzo[d]thia-zol-2-ylsulfan-yl)-N-(6-methyl-2-pyrid-yl)acetamide. Acta Crystallogr Sect E Struct Rep Online (2009) 0.99
Phosphatase type 2A-dependent and -independent pathways for ATR phosphorylation of Chk1. J Biol Chem (2007) 0.99
Discovery of 2-hydroxy-N,N-dimethyl-3-{2-[[(R)-1-(5- methylfuran-2-yl)propyl]amino]-3,4-dioxocyclobut-1-enylamino}benzamide (SCH 527123): a potent, orally bioavailable CXCR2/CXCR1 receptor antagonist. J Med Chem (2006) 0.99
CHFR protein expression predicts outcomes to taxane-based first line therapy in metastatic NSCLC. Clin Cancer Res (2013) 0.99
Targeting acetylcholinesterase to membrane rafts: a function mediated by the proline-rich membrane anchor (PRiMA) in neurons. J Biol Chem (2010) 0.99
Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. Hum Genet (2013) 0.99
A Luminex assay detects amyloid β oligomers in Alzheimer's disease cerebrospinal fluid. PLoS One (2013) 0.98
Bioactive sesquiterpenoids from the rhizomes of Acorus calamus. J Nat Prod (2012) 0.98
Two independent epidemics of HIV in Maryland. J Acquir Immune Defic Syndr (2010) 0.97
Long-term exogenous application of melatonin delays drought-induced leaf senescence in apple. J Pineal Res (2012) 0.97
Influence of drought stress on the cellular ultrastructure and antioxidant system in leaves of drought-tolerant and drought-sensitive apple rootstocks. Plant Physiol Biochem (2011) 0.97
Cell cycle G2/M arrest through an S phase-dependent mechanism by HIV-1 viral protein R. Retrovirology (2010) 0.97
Pharmacokinetics and biodistribution of near-infrared fluorescence polymeric nanoparticles. Nanotechnology (2009) 0.97
The mitigation effects of exogenous melatonin on salinity-induced stress in Malus hupehensis. J Pineal Res (2012) 0.97
Class I HDACs are mediators of smoke carcinogen-induced stabilization of DNMT1 and serve as promising targets for chemoprevention of lung cancer. Cancer Prev Res (Phila) (2014) 0.97
Glutathione peroxidase 1 gene polymorphism and risk of recurrence in patients with superficial bladder cancer. Urology (2005) 0.96
Peptide-conjugated polymeric micellar nanoparticles for Dual SPECT and optical imaging of EphB4 receptors in prostate cancer xenografts. Biomaterials (2011) 0.96
Annexin A5-conjugated polymeric micelles for dual SPECT and optical detection of apoptosis. J Nucl Med (2011) 0.96
Efficient photoelectrochemical hydrogen generation using heterostructures of Si and chemically exfoliated metallic MoS2. J Am Chem Soc (2014) 0.95
Association between lifetime cigarette smoking and lewy body accumulation. Brain Pathol (2009) 0.95
Fluorescent avidin-bound silver particle: a strategy for single target molecule detection on a cell membrane. Anal Chem (2009) 0.95
[Adult acute lymphoblastic leukemia with atypical BCR-ABL transcript e1a3: a case report and literature review]. Zhonghua Xue Ye Xue Za Zhi (2013) 0.95
Ascorbate biosynthesis during early fruit development is the main reason for its accumulation in kiwi. PLoS One (2010) 0.94
Heritable targeted inactivation of myostatin gene in yellow catfish (Pelteobagrus fulvidraco) using engineered zinc finger nucleases. PLoS One (2011) 0.94
HIV-1 viral protein R (Vpr) & host cellular responses. Indian J Med Res (2005) 0.94
Enhancing the power of genetic association studies through the use of silver standard cases derived from electronic medical records. PLoS One (2013) 0.94